Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04500509
Status:
COMPLETED
Last Update Posted:
2022-01-19
First Post:
2020-08-03
Brief Title:
Diclofenac Potassium With or Without Vaginal Dinoprostone Prior to Hysterosalpingography
Sponsor:
Aswan University Hospital
Organization:
Aswan University Hospital
Study Overview
Official Title:
Diclofenac Potassium With or Without Vaginal Dinoprostone Prior to Hysterosalpingography in Primarily Infertile Patients a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of our study is to determine the efficacy of oral diclofenac potassium with or without vaginal dinoprostone prior to hysterosalpingography in primarily infertile patients on the pain scores during HSG
Detailed Description:
hysterosalpingography is a diagnosis procedure in the evaluation of infertile women and considered to be the traditional and the gold standard in the assessment of the patency of the fallopian tubes The major disadvantage of hysterosalpingography is pain In a study reported the patients complained of moderate to severe pain during the procedure It is reported that some patients undergoing hysterosalpingography was more stressful and anxiety and effect on pain scores
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None